🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2, single-arm trial designed to assess the clinical benefit...
Status
Completed
Location
Queen Mary Hospital
Start Date
2020-07-03
Trial ID
NCT05471674
Treatments Being Tested
The purpose of this phase 2 study is to assess the feasibility and efficacy...
Status
Terminated
Location
Duke University Medical Center
Start Date
2020-11-04
Trial ID
NCT04434560
Treatments Being Tested
This is a multi-center, stratified and single-blinded Phase 2 trial of neoa...
Status
Completed
Location
IRCCS Ospedale San Raffaele Hospital Vita-Salute San Raffaele University
Start Date
2023-09-06
Trial ID
NCT06059547
Treatments Being Tested
Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2020-01-01
Trial ID
NCT04013854
Treatments Being Tested
This research study is evaluating a new drug called "nivolumab" as a possib...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-20
Trial ID
NCT02903381
Treatments Being Tested
This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadju...
Status
Recruiting
Location
University of California, Irvine
Start Date
2025-08-21
Trial ID
NCT06624475
Treatments Being Tested
This is a multi-center Phase II randomized study. We plan to enroll 78 pati...
Status
Terminated
Location
City of Hope
Start Date
2018-06-26
Trial ID
NCT03547999
Treatments Being Tested
This phase II trial tests how well adding lisocabtagene maraleucel (liso-ce...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2023-06-02
Trial ID
NCT05672173
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested
This research study is studying the drugs called NeoVax (a new type of pers...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2022-01-03
Trial ID
NCT04930783
Treatments Being Tested